Cargando…

Food and drug regulation in an era of globalized markets /

Food and Drug Regulation in an Era of Globalized Markets provides a synthesized look at the pressures that are impacting today's markets, including trade liberalization, harmonization initiatives between governments, increased aid activities to low-and middle-income countries, and developing ph...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Halabi, Sam F. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Amsterdam ; Boston : Academic Press, an imprint of Elsevier, [2015]
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBOOKCENTRAL_ocn919611878
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cnu|||unuuu
008 150902t20152015ne ob 001 0 eng d
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d N$T  |d YDXCP  |d IDEBK  |d OPELS  |d CDX  |d EBLCP  |d OCLCF  |d D6H  |d OCLCQ  |d U3W  |d CUY  |d ZCU  |d MERUC  |d AU@  |d FEM  |d LOA  |d ICG  |d MERER  |d K6U  |d COCUF  |d OCLCQ  |d VT2  |d DKC  |d OCLCQ  |d ESU  |d UK7LJ  |d HS0  |d UWK  |d NLE  |d SXB  |d UHL  |d LDP  |d EUN  |d OCLCQ  |d QGK  |d OCLCO  |d INARC  |d COO  |d OCLCQ  |d OCLCO  |d OCLCL 
019 |a 928767005  |a 968043852  |a 969044783  |a 1058408889  |a 1088961524  |a 1097098724  |a 1155994937  |a 1162283423  |a 1164897561  |a 1166212274  |a 1168702867  |a 1172298081  |a 1203853789  |a 1204876443  |a 1221572141  |a 1224710539  |a 1227629396  |a 1228601762  |a 1241958506  |a 1259273098 
020 |a 9780128025505  |q (electronic bk.) 
020 |a 0128025506  |q (electronic bk.) 
020 |a 0128023112 
020 |a 9780128023112 
020 |z 9780128023112 
024 3 |a 9780128023112 
029 1 |a AU@  |b 000056987879 
029 1 |a AU@  |b 000062547988 
029 1 |a CHBIS  |b 010796055 
029 1 |a CHNEW  |b 001013097 
029 1 |a CHVBK  |b 403951739 
029 1 |a DEBSZ  |b 451528913 
029 1 |a DEBSZ  |b 482467460 
029 1 |a GBVCP  |b 835811204 
035 |a (OCoLC)919611878  |z (OCoLC)928767005  |z (OCoLC)968043852  |z (OCoLC)969044783  |z (OCoLC)1058408889  |z (OCoLC)1088961524  |z (OCoLC)1097098724  |z (OCoLC)1155994937  |z (OCoLC)1162283423  |z (OCoLC)1164897561  |z (OCoLC)1166212274  |z (OCoLC)1168702867  |z (OCoLC)1172298081  |z (OCoLC)1203853789  |z (OCoLC)1204876443  |z (OCoLC)1221572141  |z (OCoLC)1224710539  |z (OCoLC)1227629396  |z (OCoLC)1228601762  |z (OCoLC)1241958506  |z (OCoLC)1259273098 
037 |a 6657656116786027651  |b TotalBoox  |f Ebook only  |n www.totalboox.com 
050 4 |a K3636.F66 
072 7 |a LAW  |x 001000  |2 bisacsh 
082 0 4 |a 344.0423  |2 23 
049 |a UAMI 
245 0 0 |a Food and drug regulation in an era of globalized markets /  |c edited by Sam F. Halabi. 
264 1 |a Amsterdam ;  |a Boston :  |b Academic Press, an imprint of Elsevier,  |c [2015] 
264 4 |c ©2015 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file 
504 |a Includes bibliographical references and index. 
588 0 |a Vendor-supplied metadata. 
520 |a Food and Drug Regulation in an Era of Globalized Markets provides a synthesized look at the pressures that are impacting today's markets, including trade liberalization, harmonization initiatives between governments, increased aid activities to low-and middle-income countries, and developing pharmaceutical sectors in China and India. From the changing nature of packaged and processed food supply chains, to the reorientation of pharmaceutical research and funding coalesced to confront firms, regulators, and consumers are now faced with previously unknown challenges. Based on the 2014 O'Neill Institute Summer program, this book provides an international, cross-disciplinary look at the changing world of regulations and offers insights into requirements for successful implementation. 
505 0 |a Front Cover; Food and Drug Regulation in an Era of Globalized Markets; Copyright; Contents; Contributors; Foreword; Introduction; The Rise of a Global System for Food and Pharmaceuticals; Conceptualizing Food and Drug Regulation in Globalized Markets: Interdisciplinarity and Governance; The Plan of This Book; Acknowledgments; Acknowledgments; Part I: Governance, Regulation, and Vulnerabilities of Globalized Pharmaceutical Supply Chains ; Chapter 1: Addressing Emerging Challenges in the Pharmaceutical Product Development Ecosystem; Introduction. 
505 8 |a Approaches to Reduce Drug Development Costs and Speed InnovationClinical Trials: Reducing Costs, Speeding Development: New Approaches to Patient Recruitment, Study Design, and Settings; Adaptive Design; Clinical Trials: Globalization; New Approaches to Endpoints: Biomarkers, Patient Reporting, and Remote Monitoring; The Supply Chain: How Are We Vulnerable and What Are Potential Solutions?; Big (More and More) Data: Swim or Drown?; Conclusion; Chapter 2: FDA's Global Investigation and Enforcement Authority, Partnerships, and Priorities; Introduction; Adulteration, Misbranding, and GMPs. 
505 8 |a FDA Establishment InspectionsFDA Enforcement Instruments Related to Manufacturing; Foreign Inspections; Conclusion; Chapter 3: The European Medicines Agency and the Regulation of Medicines in the European Union; Introduction; Approval of Drugs in Europe; The European Medicines Agency: Its Role and Activities; Ema Support In The Early Stages Of Drug Development; The Centralized Procedure AT WORK; Assessment overview; Single Assessment Report; Patients in the Scientific Review Process; Transparency and the Centralized Procedure; EMA-FDA Cooperation; Cooperation in the Product Life Cycle. 
505 8 |a Cooperation in InspectionsBenefits of International Cooperation; References; Chapter 4: Human Clinical Trials and Drug Approvals: Transnational Issues; Introduction; Taking Clinical Trials Abroad; Overlapping Legal and Regulatory Requirements; Legal Landscape in the United States: FDA Oversight of Clinical Trials; Legal Landscape in the EU: EU Clinical Trial Directives and Regulation; International Legal Landscape: International Clinical Practice Standards; National and Local Legal Standards; Practical Considerations in Conducting Global Trials. 
505 8 |a Deciding Whether to Conduct the Foreign Clinical Trial Under an INDIdentifying Experienced Contractors and Contract Research Organizations; Managing Idiosyncratic Foreign Sites and Investigators; Conclusion; Further Reading; Chapter 5: Falsified and Substandard Medicines in Globalized Pharmaceutical Supply Chains: Toward Actionable Solutions; Globalization's Influence on the Pharmaceutical Supply Chain; The Effects of the Global Market for Falsified and Substandard Medicines; Barriers to Global Solutions for the Problem of Falsified and Substandard Medicines. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Drugs  |x Law and legislation. 
650 0 |a Pharmacy  |x Law and legislation. 
650 0 |a Food law and legislation. 
650 7 |a LAW  |x Administrative Law & Regulatory Practice.  |2 bisacsh 
650 7 |a Drugs  |x Law and legislation  |2 fast 
650 7 |a Food law and legislation  |2 fast 
650 7 |a Pharmacy  |x Law and legislation  |2 fast 
700 1 |a Halabi, Sam F.,  |e editor. 
758 |i has work:  |a Food and drug regulation in an era of globalized markets (Text)  |1 https://id.oclc.org/worldcat/entity/E39PD3xY9jXqhK3cj3Qy8KXWpd  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Food and drug regulation in an era of globalized markets.  |d London, England : Academic Press, ©2015  |h xli, 215 pages  |z 9780128023112 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=2197878  |z Texto completo 
938 |a Coutts Information Services  |b COUT  |n 32444816 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL2197878 
938 |a EBSCOhost  |b EBSC  |n 1058929 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n cis32444816 
938 |a Internet Archive  |b INAR  |n fooddrugregulati0000unse 
938 |a YBP Library Services  |b YANK  |n 12594708 
994 |a 92  |b IZTAP